Exchange: NASDAQ·Updated 08:07 AM EDT
PLRZ logo

PLRZ Polyrizon Ltd. Ordinary Shares

$11.66
$0.00
(0.00%)
Pre-Market
Prev Close $11.66
Mkt Cap$24.3M
Vol20.00

About PLRZ

Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel.
52

Neutral Sentiment

How do you feel about PLRZ?

Advertisement|Remove ads.